Table 4.
Comparison of serum lipid profile measurements between the placebo and OVJ groups.
| Variables | Placebo (n = 26) | OVJ (n = 25) | p-Value a | p-Value b | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 4 Weeks | Change | Baseline | 4 Weeks | Change | |||
| Total cholesterol (mmol/L) | 11.99 ± 0.06 | 12.44 ± 0.07 | 0.45 ± 0.05 | 12.14 ± 0.09 | 11.74 ± 0.09 | −0.40 ± 0.05 | 0.0252 (T) * | 0.7898 (T) |
| Triglyceride (mmol/L) |
6.69 ± 0.14 | 8.40 ± 0.34 | 1.70 ± 0.25 | 6.86 ± 0.18 | 6.09 ± 0.15 | −0.78 ± 0.16 | 0.0428 (W) * | 0.7702 (W) |
| HDL cholesterol (mmol/L) | 3.54 ± 0.04 | 3.31 ± 0.04 | −0.23 ± 0.02 | 3.44 ± 0.03 | 3.47 ± 0.03 | 0.03 ± 0.02 | 0.5457 (W) | 0.7069 (W) |
| LDL cholesterol (mmol/L) | 7.40 ± 0.05 | 7.65 ± 0.06 | 0.25 ± 0.05 | 7.56 ± 0.07 | 7.15 ± 0.08 | −0.41 ± 0.04 | 0.0435 (T) * | 0.7277 (T) |
| ApoB (mmol/L) |
5.10 ± 0.03 | 5.29 ± 0.03 | 0.19 ± 0.02 | 5.22 ± 0.05 | 4.91 ± 0.05 | −0.32 ± 0.02 | 0.0043 (T) ** | 0.6665 (W) |
| VLDL (mmol/L) |
1.06 ± 0.02 | 1.48 ± 0.05 | 0.43 ± 0.04 | 1.08 ± 0.03 | 1.12 ± 0.02 | 0.04 ± 0.02 | 0.1867 (W) | 0.7483 (W) |
The data points correspond to the mean ± SEM. a Change differences between the placebo and OVJ groups. The p-value was obtained from an independent t-test or Mann–Whitney U test. b Differences between the placebo and OVJ groups at baseline. The p-value was obtained from an independent t-test or Mann–Whitney U test. Statistical difference is shown by * and **, indicating p < 0.05 and p < 0.01, respectively.